XTLBNasdaqManufacturing

XTL Biopharmaceuticals Ltd (XTLB) earnings date, market-implied expected move, and options open interest by expiry

1.61

Closed15:50 ET

Open1.61Volume8,600Mkt cap$15.2MEPS-0.01

Day1.61 – 1.640%52-wk1.60 – 18.080%

XTLB

XTL Biopharmaceuticals Ltd

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

—

Calendar

Last report

—

Largest filed tie

filed ties

13F top-10 QoQ

—

Top fund weight

—

No upcoming report date for XTL Biopharmaceuticals (XTLB). No implied move.

Implied vs realized

No reported quarters.

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No linked exposure.

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

FOMC ×2.26· ±11.0% vs ±4.9% · 22 releases

eventrelease day|move|up · n×base

FOMCrate decision±11.0%12 of 22×2.26

CPIconsumer prices±8.3%7 of 10×1.71

PCEpersonal income & outlays±4.6%8 of 19×0.94

GDPgross domestic product±4.4%9 of 19×0.91

CPROFcorporate profits±4.2%7 of 12×0.87

NFPjobs report±4.0%4 of 9×0.83

PPIproducer prices±3.2%6 of 9×0.66

Bar = avg |move| to ±11% · tick = ±4.9% avg day · ×base = |move| ÷ ±4.9% · min 6 releases

Earnings history

No reported quarters.

Methodology

ties · implied moves · holdersMethod